New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 28, 2014
10:56 EDTHMSY, NRF, NKTR, PQ, DBDHigh option volume stocks: HMSY PQ NRF DBD NKTR
News For HMSY;PQ;NRF;DBD;NKTR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 3, 2015
09:26 EDTNRFOn The Fly: Pre-market Movers
Subscribe for More Information
08:25 EDTNRFNorthstar Realty 60M share Spot Secondary priced at $18.65
The company is offering 60M shares of common stock, of which 40M shares are subject to a forward sales agreement. Deutsche Bank and UBS acted as joint book running managers for the offering.
March 2, 2015
18:52 EDTNRFOn The Fly: After Hours Movers
Subscribe for More Information
16:22 EDTNRFNorthstar Realty files to sell 60M shares of common stock
Subscribe for More Information
February 27, 2015
09:08 EDTHMSYHMS Holdings reports Q4 adjusted EPS 3c, may not compare to consensus 16c
Subscribe for More Information
08:02 EDTNRFNorthstar Realty reports Q4 CAD 44c, net loss (47c) per share
Subscribe for More Information
06:12 EDTHMSYHMS Holdings reports Q4 adjusted EPS 3c, consensus 16c
Subscribe for More Information
February 26, 2015
08:40 EDTNRFNorthstar Realty to hold a conference call
Subscribe for More Information
07:32 EDTNRFNorthstar Realty announces plan to spin-off European real estate business
NorthStar Realty (NRF) announced that its board unanimously approved a plan to spin-off its European real estate business into a separate publicly-traded REIT, NorthStar Realty Europe Corp. NorthStar Realty Europe is expected to be listed on the New York Stock Exchange and the company is evaluating a dual-listing in Europe. NorthStar Realty Europe will be managed by NorthStar Asset Management Group (NSAM) pursuant to a management agreement substantially consistent with NorthStar Realty's existing management agreement with NSAM. NorthStar Realty currently owns or has under contract approximately $2B of European commercial real estate properties that will be contributed to NorthStar Realty Europe as part of the proposed spin-off. The company expects that the proposed spin-off will be treated for tax purposes as a distribution to NorthStar Realty common stockholders equal to the fair market value of the distributed NorthStar Realty Europe shares. The proposed spin-off is expected to be completed in the second half of 2015. The proposed spin-off would provide NorthStar Realty common stockholders with a separate and distinct business focused on investing in pan-European commercial real estate assets through an equity REIT structure with target leverage levels of 40-50%. The company believes that the transaction represents an opportunity to unlock value for NorthStar Realty shareholders through benchmarking NorthStar Realty Europe against publicly-traded European equity REITs, many of which trade at substantial NAV premiums and at implied capitalization rates that would translate into substantial immediate value creation for NorthStar Realty shareholders. The Portfolio is located primarily in the United Kingdom, France and Germany and is well-positioned to capitalize on improving European macroeconomic trends and property fundamentals. NorthStar Realty will continue to be a leading investor in diversified commercial real estate assets with approximately 80% of its assets in owned real estate post spin-off.
07:31 EDTNRFNorthstar Realty announces plan to spin-off European real estate business
Subscribe for More Information
February 25, 2015
13:08 EDTNKTRNektar volatility increases on start of Phase 3 study of NKTR-181
Nektar March call option implied volatility is at 87, April is at 78, May is at 74; compared to its 26-week average of 70 according to Track Data, suggesting large near term price movement on the announcement of the start of Phase 3 study of NKTR-181.
09:28 EDTNKTRNektar announces start of Phase 3 study of NKTR-181
Nektar announced the enrollment of the first patient in SUMMIT-07, its initial Phase 3 study of NKTR-181, a first-in-class, opioid analgesic molecule with a slow rate of entry into the brain. The company said this slow rate of entry is designed to reduce the euphoria that can lead to the abuse of current opioid analgesics. SUMMIT-07 will evaluate the efficacy, safety and tolerability of NKTR-181 in patients with chronic low back pain who are also opioid-naļve. NKTR-181 is a new chemical entity that was created using Nektar's proprietary small molecule polymer conjugate technology. NKTR-181 has several potential differentiating properties that are inherent to the structure of the molecule, including a slow rate of entry into the CNS as measured by pupillometry and a plasma pharmacokinetic profile that supports twice-daily oral dosing. NKTR-181 is not a reformulation of a marketed opioid, which is a commonly-used method to attempt to prevent the manipulation of existing long-acting opioid drugs into more abusable forms. NKTR-181 has been granted has been granted Fast Track designation for the treatment of moderate to severe chronic pain by the U.S. Food and Drug Administration.
February 24, 2015
17:00 EDTNKTRNektar reports Q4 EPS (35c), consensus (36c)
Subscribe for More Information
07:19 EDTDBDSusquehanna to hold a summit
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use